Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide-Reference-Cited by-同舟云学术

Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide

Published:2023-08-11 Issue:1 Volume:26 Page:1019-1031
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Berry Sasha¹,Chubb Barrie²^ORCID,Acs Annabel²,Falla Edel³,Verma Akanksha³,Malkin Samuel J. P.⁴^ORCID,Hunt Barnaby⁴,Palmer Andrew J.⁵

Affiliation:

1. Novo Nordisk Ltd, Gatwick, UK

2. Novo Nordisk A/S, Søborg, Denmark

3. IQVIA Ltd., Real World Solutions, London, UK

4. Ossian Health Economics and Communications, Basel, Switzerland

5. Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2240957

Reference50 articles.

1. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

2. 11. Chronic kidney disease and risk management: standards of medical care in diabetes-2022;Draznin B;Diabetes Care,2022

3. 12. Retinopathy, neuropathy, and foot care: standards of medical care in diabetes-2022;Draznin B;Diabetes Care,2022

4. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management [NG28]; [updated 2021 Nov; cited 2021 Nov]. Available from: https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations#blood-glucose-management-2

5. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes mellitus and heart disease;Metabolism and Target Organ Damage;2024-04-09